Archive by category Featured

Dr. Peter Pedersen Explaining the Promise of 3-BP

Dr. Peter Pedersen Explaining the Promise of 3-BP

http://videocast.nih.gov/summary.asp?live=7542 The above link is of Dr. Peter Pedersen in a NIH/NCI presentation on the exploitation of hexokinase II by 3-BP. Dr. Pedersen is an exemplary research scientist who is doing the ‘heavy-lifting’, the gritty, molecular details of cancer’s defective metabolism. When you watch the video it is impossible to not get excited about this […]

Single Cause Single Cure interviews Dominic D’Agostino, Ph.D

Single Cause Single Cure interviews Dominic D’Agostino, Ph.D

As an Assistant Professor at the University of South Florida since 2008, D’Agostino teaches students of the Morsani College of Medicine and the Department of Molecular Pharmacology and Physiology, with a focus on such topics as neuropharmacology, medical biochemistry, cell metabolism, and signaling. In his capacities as a researcher, Dominic D’Agostino enjoys support from the […]

Raffi’s Story

Raffi’s Story

In December of 2004, our 4 year old son Raffi was diagnosed with a brain tumor. After three surgeries and several failed drug protocols, it was clear that the tumor was winning. Raffi’s vision, language and motor skills deteriorated and a cascade of endocrine problems affected many vital functions. Our little fighter had done everything […]

An Unexpected Benefit of Ketosis

An Unexpected Benefit of Ketosis

The ketogenic diet is unique in its ability to simultaneously put cancer cells under metabolic stress while ‘supercharging’ normal cells capacity to deal with a variety of insults. Chemotherapy is responsible for numerous side effects that significantly detract from the patient’s quality of life, leaving people sick and exhausted. To date, few therapies have been […]

The Promise of Metabolic Therapy

The therapies that treat cancer as a metabolic disease exhibit incredible promise. The main stumbling block right now is that nobody knows how to make money from the molecules that treat cancer metabolically, because they are mostly non-patentable – so little attention gets paid. What follows is two case studies of cancer patients whom tried […]